Specific RehaCom Modules Predict Processing Speed Gains in Progressive Multiple Sclerosis

Refining Cognitive Rehabilitation in Progressive Multiple Sclerosis

Cognitive decline remains a primary driver of disability in progressive multiple sclerosis, yet clinicians lack a standardized metric for longitudinal assessment, which complicates the timing and delivery of targeted interventions [1]. In the absence of effective pharmacotherapy, non-pharmacological strategies such as computerized cognitive training have demonstrated the ability to improve immediate and delayed verbal memory and information processing speed in this population [2]. A meta-analysis of 3,091 patients further indicates that mobile health applications offer a scalable alternative to traditional therapy, yielding a small but significant effect on cognitive function (standardized mean difference = 0.28) and a moderate effect on fatigue (standardized mean difference = 0.61) [3]. However, the clinical utility of these digital tools is often hindered by high inter-patient variability and a lack of consensus regarding the most effective therapeutic components [4, 5]. To address these uncertainties, a secondary analysis of the CogEx trial (a large-scale randomized controlled trial investigating cognitive rehabilitation and aerobic exercise) provides evidence on how specific training trajectories and patient phenotypes influence long-term cognitive outcomes [6].

Quantifying Cognitive Training Trajectories

This secondary analysis of the CogEx trial evaluated data from 153 participants with progressive multiple sclerosis to determine how specific training trajectories influence cognitive recovery. The researchers focused on whether progression within individual modules of RehaCom (a computerized cognitive rehabilitation program) was associated with improvements in processing speed. Over a 12-week intervention period, participants engaged with 5 attention-based modules designed to target distinct cognitive domains. Beyond tracking training performance, the study investigated whether baseline participant characteristics could predict which individuals were most likely to respond to the intervention, providing a framework for more personalized rehabilitation strategies in a clinical setting.

To quantify cognitive changes, the researchers utilized the Symbol Digit Modalities Test (SDMT), a standard clinical tool that measures processing speed by requiring patients to pair numbers with geometric figures within a set time limit. Assessments were conducted at baseline, 12 weeks, and 6 months to capture both immediate post-treatment effects and long-term retention. The authors employed correlation and regression analyses to evaluate the associations between module-specific progression and cognitive outcomes. By mapping these trajectories, the study aimed to identify which specific components of the training software drove the most significant gains in SDMT scores, moving beyond simple measures of treatment dose such as total duration or frequency.

Module Progression and 12-Week Cognitive Outcomes

The researchers found that progression correlated significantly with SDMT improvement in 4 out of the 5 attention-based modules evaluated. When analyzing the specific impact of these training components on processing speed, the strongest correlation for SDMT improvement was observed in the Attention/Concentration module (r = .37, P < .001). This was closely followed by the Divided Attention-2 module (r = .36, P < .001). These results indicate that while general engagement with the software is beneficial, the degree of advancement in tasks requiring sustained focus and the management of multiple cognitive streams is most closely tied to measurable gains in processing speed.

To identify which patients are most likely to benefit from this intervention, the study utilized a regression model to determine independent predictors of cognitive status at the end of the treatment period. The analysis revealed that higher baseline SDMT scores independently predicted better SDMT performance at 12 weeks, suggesting that patients with higher initial processing speed retain a relative advantage. Additionally, higher premorbid IQ (a measure of cognitive reserve reflecting the brain's ability to improvise and find alternate ways of completing a task) independently predicted better SDMT performance at 12 weeks. Demographic factors and training success also contributed to the outcome, as older age and greater module progression independently predicted better SDMT performance at 12 weeks. The adjusted R2 for the 12-week prediction model was .73, demonstrating that nearly three-quarters of the variance in processing speed outcomes can be explained by these specific baseline characteristics and the patient's ability to advance through the training modules.

Long-Term Durability and Patient Phenotypes

The durability of cognitive gains was assessed at a 6-month follow-up to determine which factors influenced sustained processing speed. The researchers found that higher baseline SDMT scores predicted better SDMT performance at 6 months, indicating that initial cognitive status remains a primary determinant of long-term outcomes. Beyond baseline performance, the specific type of cognitive exercise mattered for longitudinal success. Specifically, greater progression in the Attention/Concentration module and the Divided Attention-2 module predicted better SDMT performance at 6 months. These findings suggest that mastering tasks requiring focused attention and the ability to manage multiple simultaneous information streams provides a more lasting benefit to processing speed than other forms of cognitive training.

Demographic factors also played a significant role in the 6-month outcomes, revealing specific patient phenotypes that may be more responsive to this intervention. The analysis showed that older age and female sex predicted better SDMT performance at 6 months. When these variables were combined with module progression data, the adjusted R2 for the 6-month prediction model was .71, meaning the model accounted for 71 percent of the variance in long-term processing speed scores. Ultimately, the study demonstrates that processing speed gains in progressive multiple sclerosis were related to both module-specific progression and participant characteristics. For the practicing clinician, these results support a precision approach to cognitive rehabilitation. Rather than prescribing a generic dose of brain-training exercises, neurologists and rehabilitation specialists can use these findings to tailor specific software modules to individual cognitive profiles, maximizing the chances of meaningful, sustained recovery.

References

1. Ezegbe C, Zarghami A, Mei IVD, Alty J, Honan CA, Taylor B. Instruments measuring change in cognitive function in multiple sclerosis: A systematic review. Brain and Behavior. 2023. doi:10.1002/brb3.3009

2. Renner A, Bätge S, Filser M, Lau S, Pöttgen J, Penner I. Non-pharmacological randomized intervention trial for the management of neuropsychological symptoms in outpatients with progressive multiple sclerosis. Applied neuropsychology. Adult. 2023. doi:10.1080/23279095.2023.2233648

3. Bonnechère B, Rintala A, Spooren A, Lamers I, Feys P. Is mHealth a Useful Tool for Self-Assessment and Rehabilitation of People with Multiple Sclerosis? A Systematic Review. Brain Sciences. 2021. doi:10.3390/brainsci11091187

4. Bonanno M, Luca RD, Nunzio AMD, Quartarone A, Calabrò RS. Innovative Technologies in the Neurorehabilitation of Traumatic Brain Injury: A Systematic Review. Brain Sciences. 2022. doi:10.3390/brainsci12121678

5. Irazoki E, Contreras-Somoza LM, Toribio-Guzmán JM, Río CJ, Roest HGVD, Franco M. Technologies for Cognitive Training and Cognitive Rehabilitation for People With Mild Cognitive Impairment and Dementia. A Systematic Review. Frontiers in Psychology. 2020. doi:10.3389/fpsyg.2020.00648

6. Feinstein A, Amato MP, Brichetto G, et al. Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx). BMC Neurology. 2020. doi:10.1186/s12883-020-01772-7